NY-ESO-1-specific CD8 T cell response in NY-ESO-1 seropositive metastatic melanoma patients treated with ipilimumab correlates with clinical benefit Meeting Abstract


Authors: Yuan, J. D.; Gnjatic, S.; Adamow, M.; Ginsberg, B.; Rasalan, T. S.; Ritter, E.; Gallardo, H. F.; Xu, Y.; Pogoriler, E.; Panageas, K. S.; Yang, A.; Terzulli, S.; Ritter, G.; Old, L. J.; Allison, J. P.; Wolchok, J. D.
Abstract Title: NY-ESO-1-specific CD8 T cell response in NY-ESO-1 seropositive metastatic melanoma patients treated with ipilimumab correlates with clinical benefit
Meeting Title: 25th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer
Journal Title: Journal of Immunotherapy
Volume: 33
Issue: 8
Meeting Dates: 2010 Oct 2-4
Meeting Location: Washington D.C.
ISSN: 1524-9557
Publisher: Lippincott Williams & Wilkins  
Date Published: 2010-10-01
Start Page: 913
End Page: 914
Language: English
ACCESSION: ISI:000282131800180
PROVIDER: wos
Notes: --- - Meeting Abstract - "Source: Wos"